tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MLTX Stock Latest News

Optimistic Outlook for MoonLake Immunotherapeutics: Promising Developments and Market Opportunities for Sonelokimab
RatingsOptimistic Outlook for MoonLake Immunotherapeutics: Promising Developments and Market Opportunities for Sonelokimab
1d ago
MLTX
Piper Sandler bullish on Avalo Therapeutics, initiates with an Overweight
PremiumThe Fly
Piper Sandler bullish on Avalo Therapeutics, initiates with an Overweight
4d ago
AVTX
MLTX
MoonLake Immunotherapeutics: Buy Rating Backed by Promising SLK Data and Strong Financial Position
PremiumRatings
MoonLake Immunotherapeutics: Buy Rating Backed by Promising SLK Data and Strong Financial Position
5d ago
MLTX
Moonlake Immunotherapeutics Faces Hurdles in Commercializing SLK Despite Potential Approvals
PremiumCompany Announcements
Moonlake Immunotherapeutics Faces Hurdles in Commercializing SLK Despite Potential Approvals
5d ago
MLTX
Buy Rating for MoonLake Immunotherapeutics Driven by Promising Clinical Programs and Market Potential
PremiumRatings
Buy Rating for MoonLake Immunotherapeutics Driven by Promising Clinical Programs and Market Potential
6d ago
MLTX
MoonLake Immunotherapeutics: Strong Buy Rating Amid Promising Phase 3 Trials and Robust Financial Position
PremiumRatingsMoonLake Immunotherapeutics: Strong Buy Rating Amid Promising Phase 3 Trials and Robust Financial Position
6d ago
MLTX
Buy Rating for MoonLake Immunotherapeutics: Strong Financials and Promising Clinical Developments
Premium
Ratings
Buy Rating for MoonLake Immunotherapeutics: Strong Financials and Promising Clinical Developments
6d ago
MLTX
MoonLake Immunotherapeutics: Promising Future with Strong Financial Position and Clinical Advancements
Premium
Ratings
MoonLake Immunotherapeutics: Promising Future with Strong Financial Position and Clinical Advancements
6d ago
MLTX
MoonLake Immunotherapeutics reports Q4 EPS (72c), consensus (59c)
PremiumThe Fly
MoonLake Immunotherapeutics reports Q4 EPS (72c), consensus (59c)
6d ago
MLTX
Closing Bell Movers: JB Hunt down 9% after Q4 earnings miss
PremiumThe Fly
Closing Bell Movers: JB Hunt down 9% after Q4 earnings miss
2M ago
EYE
LIF
MoonLake Immunotherapeutics upgraded to Buy from Neutral at Goldman Sachs
PremiumThe Fly
MoonLake Immunotherapeutics upgraded to Buy from Neutral at Goldman Sachs
2M ago
MLTX
Goldman upgrades MoonLake to Buy into hidradenitis suppurativa data
PremiumThe Fly
Goldman upgrades MoonLake to Buy into hidradenitis suppurativa data
2M ago
MLTX
MoonLake Immunotherapeutics price target raised to $81 from $71 at BTIG
PremiumThe FlyMoonLake Immunotherapeutics price target raised to $81 from $71 at BTIG
2M ago
MLTX
MoonLake Immunotherapeutics initiates three new clinical trials
Premium
The Fly
MoonLake Immunotherapeutics initiates three new clinical trials
2M ago
MLTX
Capricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
Premium
The Fly
Capricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
3M ago
CAPR
GILD
MoonLake Immunotherapeutics Announces Board Changes and Incentives
PremiumCompany Announcements
MoonLake Immunotherapeutics Announces Board Changes and Incentives
3M ago
8K
MLTX
MoonLake Immunotherapeutics management to meet with Oppenheimer
PremiumThe Fly
MoonLake Immunotherapeutics management to meet with Oppenheimer
4M ago
MLTX
MoonLake Immunotherapeutics announces first patients screened in IZAR program
PremiumThe Fly
MoonLake Immunotherapeutics announces first patients screened in IZAR program
4M ago
MLTX
MoonLake Immunotherapeutics Reports Q3 2024 Financial Results
PremiumCompany Announcements
MoonLake Immunotherapeutics Reports Q3 2024 Financial Results
4M ago
MLTX
MoonLake Immunotherapeutics reports Q3 EPS (56c), consensus (43c)
PremiumThe FlyMoonLake Immunotherapeutics reports Q3 EPS (56c), consensus (43c)
4M ago
MLTX
MoonLake Immunotherapeutics sees cash runway into end of 2026
Premium
The Fly
MoonLake Immunotherapeutics sees cash runway into end of 2026
4M ago
MLTX
MoonLake Immunotherapeutics assumed with an Outperform at Wedbush
Premium
The Fly
MoonLake Immunotherapeutics assumed with an Outperform at Wedbush
4M ago
MLTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >